Our latest research and evaluations is published regularly in:
- 6 May 2021
Biological medicines and COVID-19 FAQs
Biological medicines are being studied for their effectiveness and safety as a treatment for COVID-19. Here’s what we know so far.
- 27 April 2021
Nicotine vaping products: practice implications of scheduling changes
Prepare yourself and your practice for scheduling changes to nicotine coming into effect from 1 October 2021.
- 23 February 2021
Focus on heart failure
How active is your role in managing heart failure and helping patients stay out of hospital and live better, longer lives?
- Medicinewise News
- 11 November 2020
Mild asthma: practical considerations and a new treatment option
Managing asthma is an interplay of practical considerations, shared decision-making and treatment guidelines. We discuss what to consider when navigating treatment options for mild asthma, including the new reliever option of low-dose budesonide + formoterol.
- 30 October 2020
Dementia and changed behaviours: supporting the person at the centre
Person-centred care for people with changed behaviours relies on comprehensive assessment and a multidisciplinary approach that includes the person and their carers.
- 17 September 2020
Hydroxychloroquine: did COVID-19 change GP prescribing?
A study looking at prescribing patterns for hydroxychloroquine during the first months of the COVID-19 pandemic in Australia
- 2 September 2020
Ivermectin and COVID-19
Emerging evidence about the use of this antiparasitic medicine to treat COVID-19
- 3 August 2020
Vitamin D and COVID-19
Vitamin D is important for bone, muscle and dental health but there has been no strong evidence to show that taking vitamin D supplements will make you less susceptible to COVID-19.
Contact our media team
If you are a journalist seeking comment on a story or more information on any of our programs or campaigns please contact the NPS MedicineWise media team
on 02 8217 8667.
For urgent media requests outside of office hours, please call 0419 618 365. If your request is not urgent you can also email an enquiry.
Publications & Programs
Australian Prescriber is an independent peer-reviewed journal that provides critical commentary on drugs and therapeutics for health professionals.
Peak stories have included the top 10 most expensive drugs, eradication of Hepatitis C, drug seeking behaviours in people and more.
RADAR provides health professionals with timely information on new drugs, medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.
Peak stories have included warfarin, campaigns urging doctors to seeing health reps, and treating Hepatitis C.